Will SARS-CoV-2 variants of concern affect the promise of vaccines?

par Gupta, Ravindra K.
Publié dans Nat Rev Immunol (2021)

Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?

par Gupta, Ravindra K.
Publié dans Nat Rev Immunol (2021)

Ultra Structural Characterisation of Tetherin - a Protein Capable of Preventing Viral Release from the Plasma Membrane

par Gupta, Ravindra K., Towers, Greg J.
Publié 2010

A Tail of Tetherin: How Pandemic HIV-1 Conquered the World

par Gupta, Ravindra K., Towers, Greg J.
Publié 2009

Management of paediatric HIV-1 resistance

par Gupta, Ravindra K., Gibb, Diana, Pillay, Deenan
Publié 2009

Mumps and the UK epidemic 2005

par Gupta, Ravindra K, Best, Jennifer, MacMahon, Eithne
Publié 2005

Bacterial Pneumonia and Pandemic Influenza Planning

par Gupta, Ravindra K., George, Robert, Nguyen-Van-Tam, Jonathan S.
Publié 2008

TLR4-Mediated Pathway Triggers Interferon-Independent G0 Arrest and Antiviral SAMHD1 Activity in Macrophages

par Mlcochova, Petra, Winstone, Helena, Zuliani-Alvarez, Lorena, Gupta, Ravindra K.
Publié dans Cell Rep (2020)

Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1

par Ferreira, Isabella A. T. M., Porterfield, J. Zachary, Gupta, Ravindra K., Mlcochova, Petra
Publié dans Viruses (2020)

The “Silent” Global Burden of Congenital Cytomegalovirus

par Manicklal, Sheetal, Emery, Vincent C., Lazzarotto, Tiziana, Boppana, Suresh B., Gupta, Ravindra K.
Publié 2013

Vpx complementation of ‘non-macrophage tropic’ R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages

par Mlcochova, Petra, Watters, Sarah A, Towers, Greg J, Noursadeghi, Mahdad, Gupta, Ravindra K
Publié 2014

Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion

par Gupta, Ravindra K., Hué, Stéphane, Schaller, Torsten, Verschoor, Ernst, Pillay, Deenan, Towers, Greg J.
Publié 2009

Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control

par Watters, Sarah A., Mlcochova, Petra, Maldarelli, Frank, Goonetilleke, Nilu, Pillay, Deenan, Gupta, Ravindra K.
Publié dans PLoS One (2016)

DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV‐1 infection of macrophages

par Mlcochova, Petra, Caswell, Sarah J, Taylor, Ian A, Towers, Greg J, Gupta, Ravindra K
Publié dans EMBO J (2017)

Public Understanding of Pandemic Influenza, United Kingdom

par Gupta, Ravindra K., Toby, Martina, Bandopadhyay, Gagori, Cooke, Mary, Gelb, David, Nguyen-Van-Tam, Jonathan S.
Publié 2006

Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings

par Hosseinipour, Mina C., Gupta, Ravindra K, Van Zyl, Gert, Eron, Joseph J., Nachega, Jean B.
Publié 2013

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

par Gupta, Ravindra K, Van de Vijver, David A M C, Manicklal, Sheetal, Wainberg, Mark A
Publié 2013

HIV Cerebrospinal Fluid Escape and Neurocognitive Pathology in the Era of Combined Antiretroviral Therapy: What Lies Beneath the Tip of the Iceberg in Sub-Saharan Africa?

par Collier, Dami Aderonke, Haddow, Lewis, Brijkumar, Jay, Moosa, Mahomed-Yunus S., Benjamin, Laura, Gupta, Ravindra K.
Publié dans Brain Sci (2018)

Virological efficacy of PI monotherapy for HIV-1 in clinical practice

par El Bouzidi, Kate, Collier, Dami, Nastouli, Eleni, Copas, Andrew J., Miller, Robert F., Gupta, Ravindra K.
Publié dans J Antimicrob Chemother (2016)

Full length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays

par GUPTA, Ravindra K, KOHLI, Arinder, McCORMICK, Adele L., TOWERS, Greg J., PILLAY, Deenan, PARRY, Chris M
Publié 2010